Price (delayed)
$233.74
Market cap
$36.72B
P/E Ratio
50.92
Dividend/share
N/A
EPS
$4.59
Enterprise value
$37.91B
Illumina, Inc. is an American company. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a
There are no recent dividends present for ILMN.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.